Literature DB >> 23338236

Distinct populations of innate CD8+ T cells revealed in a CXCR3 reporter mouse.

Steve Oghumu1, Ran Dong, Sanjay Varikuti, Todd Shawler, Thomas Kampfrath, Cesar A Terrazas, Claudio Lezama-Davila, Brian M M Ahmer, Caroline C Whitacre, Sanjay Rajagopalan, Richard Locksley, Arlene H Sharpe, Abhay R Satoskar.   

Abstract

CXCR3, expressed mainly on activated T and NK cells, is implicated in a host of immunological conditions and can contribute either to disease resolution or pathology. We report the generation and characterization of a novel CXCR3 internal ribosome entry site bicistronic enhanced GFP reporter (CIBER) mouse in which enhanced GFP expression correlates with surface levels of CXCR3. Using CIBER mice, we identified two distinct populations of innate CD8(+) T cells based on constitutive expression of CXCR3. We demonstrate that CXCR3(+) innate CD8(+) T cells preferentially express higher levels of Ly6C and CD122, but lower levels of CCR9 compared with CXCR3(-) innate CD8(+) T cells. Furthermore, we show that CXCR3(+) innate CD8(+) T cells express higher transcript levels of antiapoptotic but lower levels of proapoptotic factors, respond more robustly to IL-2 and IL-15, and produce significantly more IFN-γ and granzyme B. Interestingly, CXCR3(+) innate CD8(+) T cells do not respond to IL-12 or IL-18 alone, but produce significant amounts of IFN-γ on stimulation with a combination of these cytokines. Taken together, these findings demonstrate that CXCR3(+) and CXCR3(-) innate CD8(+) T cells are phenotypically and functionally distinct. These newly generated CIBER mice provide a novel tool for studying the role of CXCR3 and CXCR3-expressing cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23338236      PMCID: PMC3683850          DOI: 10.4049/jimmunol.1201170

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  33 in total

1.  Self-antigen maintains the innate antibacterial function of self-specific CD8 T cells in vivo.

Authors:  Salim Dhanji; Michael T Chow; Hung-Sia Teh
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 2.  Signalling through TEC kinases regulates conventional versus innate CD8(+) T-cell development.

Authors:  Leslie J Berg
Journal:  Nat Rev Immunol       Date:  2007-06       Impact factor: 53.106

3.  Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse.

Authors:  Masahito Kamanaka; Sean T Kim; Yisong Y Wan; Fayyaz S Sutterwala; Maria Lara-Tejero; Jorge E Galán; Ed Harhaj; Richard A Flavell
Journal:  Immunity       Date:  2006-11-30       Impact factor: 31.745

Review 4.  The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design.

Authors:  Thomas A Waldmann
Journal:  Nat Rev Immunol       Date:  2006-08       Impact factor: 53.106

5.  Development of a novel chemokine-mediated in vivo T cell recruitment assay.

Authors:  Gabriele S V Campanella; Benjamin D Medoff; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  J Immunol Methods       Date:  2008-01-09       Impact factor: 2.303

6.  Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria.

Authors:  Gabriele S V Campanella; Andrew M Tager; Joseph K El Khoury; Seddon Y Thomas; Tabitha A Abrazinski; Lindsay A Manice; Richard A Colvin; Andrew D Luster
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

7.  Memory phenotype CD8+ T cells with innate function selectively develop in the absence of active Itk.

Authors:  Jianfang Hu; Nisebita Sahu; Elizabeth Walsh; Avery August
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

8.  IFN-gamma and STAT1 are required for efficient induction of CXC chemokine receptor 3 (CXCR3) on CD4+ but not CD8+ T cells.

Authors:  Joseph Barbi; Steve Oghumu; Claudio M Lezama-Davila; Abhay R Satoskar
Journal:  Blood       Date:  2007-09-15       Impact factor: 22.113

9.  An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3.

Authors:  Daniel J J Carr; Todd Wuest; John Ash
Journal:  J Interferon Cytokine Res       Date:  2008-04       Impact factor: 2.607

10.  Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis.

Authors:  Karkada Mohan; Thomas B Issekutz
Journal:  J Immunol       Date:  2007-12-15       Impact factor: 5.422

View more
  13 in total

Review 1.  The chemokine system in innate immunity.

Authors:  Caroline L Sokol; Andrew D Luster
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

2.  Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Authors:  Steve Oghumu; James C Stock; Sanjay Varikuti; Ran Dong; Cesar Terrazas; Jessica A Edwards; Chad A Rappleye; Ariel Holovatyk; Arlene Sharpe; Abhay R Satoskar
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Granzyme-mediated regulation of host defense in the liver in experimental Leishmania donovani infection.

Authors:  Henry W Murray; Marisa Mitchell-Flack; Hua Zheng; Xiaojing Ma
Journal:  Infect Immun       Date:  2014-12-01       Impact factor: 3.441

4.  CXCR3 expression defines a novel subset of innate CD8+ T cells that enhance immunity against bacterial infection and cancer upon stimulation with IL-15.

Authors:  Steve Oghumu; Cesar A Terrazas; Sanjay Varikuti; Jennifer Kimble; Stephen Vadia; Lianbo Yu; Stephanie Seveau; Abhay R Satoskar
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

5.  Cutting Edge: CXCR3 Escapes X Chromosome Inactivation in T Cells during Infection: Potential Implications for Sex Differences in Immune Responses.

Authors:  Steve Oghumu; Sanjay Varikuti; James C Stock; Greta Volpedo; Noushin Saljoughian; Cesar A Terrazas; Abhay R Satoskar
Journal:  J Immunol       Date:  2019-06-28       Impact factor: 5.422

6.  Cxcr3-expressing leukocytes are necessary for neurofibroma formation in mice.

Authors:  Jonathan S Fletcher; Jianqiang Wu; Walter J Jessen; Jay Pundavela; Jacob A Miller; Eva Dombi; Mi-Ok Kim; Tilat A Rizvi; Kashish Chetal; Nathan Salomonis; Nancy Ratner
Journal:  JCI Insight       Date:  2019-02-07

7.  Th17 cells inhibit CD8+ T cell migration by systematically downregulating CXCR3 expression via IL-17A/STAT3 in advanced-stage colorectal cancer patients.

Authors:  Dan Wang; Weina Yu; Jingyao Lian; Qian Wu; Shasha Liu; Li Yang; Feng Li; Lan Huang; Xinfeng Chen; Zhen Zhang; Aitian Li; Jinbo Liu; Zhenqiang Sun; Junxia Wang; Weitang Yuan; Yi Zhang
Journal:  J Hematol Oncol       Date:  2020-06-05       Impact factor: 17.388

8.  Pathogen Evasion of Chemokine Response Through Suppression of CXCL10.

Authors:  Alejandro L Antonia; Kyle D Gibbs; Esme D Trahair; Kelly J Pittman; Amelia T Martin; Benjamin H Schott; Jeffrey S Smith; Sudarshan Rajagopal; J Will Thompson; Richard Lee Reinhardt; Dennis C Ko
Journal:  Front Cell Infect Microbiol       Date:  2019-08-07       Impact factor: 5.293

9.  CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential.

Authors:  Gabriele De Simone; Emilia M C Mazza; Antonino Cassotta; Alexey N Davydov; Mirela Kuka; Veronica Zanon; Federica De Paoli; Eloise Scamardella; Maria Metsger; Alessandra Roberto; Karolina Pilipow; Federico S Colombo; Elena Tenedini; Enrico Tagliafico; Luca Gattinoni; Domenico Mavilio; Clelia Peano; David A Price; Satya P Singh; Joshua M Farber; Valentina Serra; Francesco Cucca; Francesco Ferrari; Valeria Orrù; Edoardo Fiorillo; Matteo Iannacone; Dmitriy M Chudakov; Federica Sallusto; Enrico Lugli
Journal:  J Immunol       Date:  2019-11-18       Impact factor: 5.422

10.  CXCR3-dependent CD4⁺ T cells are required to activate inflammatory monocytes for defense against intestinal infection.

Authors:  Sara B Cohen; Kirk J Maurer; Charlotte E Egan; Steve Oghumu; Abhay R Satoskar; Eric Y Denkers
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.